Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York, USA
Biography
Charles R Bridges currently work as a Chief Technology Officer in The Janssen Pharmaceutical Companies of Johnson & Johnson. The main area of Charles R Bridges research is Gene and protein-based therapies, Hypertension, Interventional Cardiology, Myocarditis, Stem Cell and Regenerative Biology, Cardiovascular, Metabolism and Pulmonary Hypertension Therapeutic Areas. Charles R Bridges studies have been published in some of main worldwide journals.
+44 1223 790975